Quote from Anaconda:
Maybe to those who cannot keep their ADHD under control combined with subpar reading comprehension.
They barely passed one of the key protocols required by the FDA. "Provenge reduced the risk of death by 22.5% compared to the control arm." FDA requirement is 22%.
But wait, there is more.
"In a presentation to doctors Tuesday at a meeting of the American Urological Association here, investigators who led the 512-patient study known as Impact, said 31.7% of men who received the medicine were still alive after three years, compared with 23% who were given a placebo."
31.7% versus 23%? Considering how much these studies get skewed toward the result wanted, that is simply pathetic. This drug is worthless.
Now look at the expectations of this crappy biotech, which blew it up to be one to cure cancer. And compare it with the shitty results, another cancer drug that costs a fortune and buys you a few extra months of agony. There are plenty of those out there already, which are cheaper than DNDN's as they are being mass produced.
Basic common sense, go buy some if you can find it.